Predictors of achieving minimal manifestations or better status in ocular myasthenia gravis with immunotherapy
{{output}}
Background: Ocular myasthenia gravis (MG), while less severe than generalized MG, significantly impairs quality of life due to its impact on vision and daily activities. Immunotherapy is a key treatment, yet the optimal timing fo... ...
